
Director of entrepreneurship at MEMP talks about entrepreneurship in Brazil, the new NIB program, and advancements in medicinal cannabis

Study conducted in the Netherlands interviewed 367 people; most of them do not discuss the use of natural products with their doctors in treating Parkinson's

Data analysis tool mapped 39 plantations across the country

Experts discuss the importance of integrativity in cannabinoid dentistry and the legal certainty of the process

Minas is one of the few states that still do not have approved legislation on the free distribution of cannabidiol-based medicines

Unveiling the symptoms, consequences, and benefits of cannabis in treating the disease

CBCM 2024 promises new perspectives on treatments and research

Discovering the hidden virtues of a distinct cannabinoid

Through dialogue, the entities seek to regulate associative cultivation for medicinal purposes in Brazil

"The political and regulatory context of hemp" and "Hemp and Brazilian Agro" will be topics of the Agro & Tech module of the Brazilian Medicinal Cannabis Congress in May 2024

In a live session, the president of the Latin American Industrial Hemp Association (LAIHA) states that the pre-defined limit of 0.3% THC does not mean that hemp is not cannabis.

Researcher and confirmed speaker of CBCM also talks about the importance of regulating the production and consumption of cannabis in Brazil

The purpose of the PL is to encourage research and distribution by SUS of cannabis-based medications in Rio Grande do Sul

The Federal District and other states are discussing the creation of laws to decriminalize marijuana cultivation for medicinal and scientific use

How can the debate on the uses of cannabis be expanded in Brazil?

Find out about the job opportunities in the cannabis market. This week, positions for CRM Analyst, Jr. Navigator Nurse, Full Stack Developer, Designer - Campaign Construction, and Media Performance Analyst.

The event is a pioneer in Brazil and worldwide in addressing medicinal cannabis in sports and promoting quality of life.

After learning about the benefits of medicinal cannabis through family use, the psychiatrist began prescribing it to his patients. He quickly became a reference on the subject in the city of Rio de Janeiro.

The company, headquartered in Campinas, wants to take advantage of the path paved from RDC 327 and establish itself as an alternative in the Brazilian medicinal cannabis market with the development of studies, product launches, and, who knows, in the supply

The case of Tales Loss (C), who suffers from an autoimmune disease, spondyloarthritis - which causes inflammations and intense pain crises - was one that inspired the founding of the first patient association in Espírito Santo